Citurgia BioChem Financials

NSE: CITURGIBIO | BSE: 506373

₹106.55

₹-1.05 (-0.98%)

As on 07-Sep-2026IST

Market cap

₹1,407 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

P/B Ratio

-136.4

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	--	--	--	--	--	--
Total Income	--	--	--	--	--	--
Total Expenditure	0.52	0.20	0.25	0.21	0.18	0.37
EBITDA	-0.52	-0.20	-0.25	-0.21	-0.18	-0.37
Depreciation	0.23	0.23	0.23	0.23	0.23	0.24
EBIT	-0.74	-0.42	-0.48	-0.44	-0.40	-0.61
Interest	--	0.00	0.00	0.00	0.00	0.00
Other Income	--	--	--	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-0.74	-0.42	-0.48	-0.44	-0.40	-0.61
Provision for Tax	--	--	--	--	--	--
Profit after Tax	-0.74	-0.42	-0.48	-0.44	-0.40	-0.61

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	-7.73	-6.99	-6.57	-6.09	-5.66	-5.25
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	8.69	8.63	8.56	8.35	8.29	8.29
Current Liabilities	9.51	9.13	9.05	8.94	8.80	8.56
Total Liabilities	10.47	10.76	11.04	11.19	11.43	11.60

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	2.15	2.45	2.74	2.92	3.18	3.33
Current Assets	8.32	8.32	8.30	8.28	8.25	8.27
Total Assets	10.47	10.76	11.04	11.19	11.43	11.60
Total Debt*	--	6.83	6.77	6.55	6.50	6.50
Net Current Assets	-1.19	-0.81	-0.74	-0.66	-0.54	-0.30
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	-0.12	-0.14	-0.07	-0.03	-0.15
Cash Flow from Investing Activities	--	0.07	-0.05	0.04	0.01	0.15
Cash from Financing Activities	--	0.06	0.22	0.06	--	0.01
Net Cash Inflow / Outflow	--	0.01	0.03	0.02	-0.01	0.01

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	-0.06	-0.16	-0.18	-0.17	-0.15	-0.23
Cash EPS (₹)	--	-0.07	-0.09	-0.08	-0.07	-0.14
Adjusted Book Value (₹)	--	-3.59	-3.43	-3.25	-3.09	-2.93
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-0.04	-0.05	-0.03	-0.01	-0.06
Free Cash Flow per Share (₹)	--	-0.04	-0.05	-0.03	-0.01	-0.06

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	-1,964.73	-144.16	-67.22	-38.82	-39.64
ROE (%)	--	--	--	--	--	--
ROA (%)	-6.98	-3.88	-4.28	-3.86	-3.51	-5.19
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-65.77	11.06	-9.03	-7.92	33.93	-55.04
Net Profit Growth (%)	-65.77	11.04	-9.03	-7.94	33.96	-54.45
EPS Growth (%)	-65.49	11.06	-9.02	-7.91	33.94	-54.40
Book Value Growth (%)	--	-4.67	-5.53	-5.35	-5.21	-8.57

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	--	--	--	--	--	--
Price / Book Value	-136.43	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2,746.11	-167.94	-132.40	-156.27	-184.10	-88.07
Close Price (₹)	117.55	--	--	--	--	--
High Price (₹)	212.00	--	--	--	--	--
Low Price (₹)	47.40	--	--	--	--	--
Market Cap (₹ Cr)	1,407.48	--	--	--	--	--

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	-0.89	-0.72	-0.75	-0.76	-0.80	-0.84
Short term debt to equity ratio	--	0.00	-0.01	-0.01	-0.01	-0.01
Current Ratio	0.87	0.91	0.92	0.93	0.94	0.97
Quick Ratio	0.03	0.03	0.03	0.02	0.02	0.02
Interest Coverage	--	-2,681.66	-7,093.47	-4,564.75	--	-2,016.36

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)